Genomics England is a biotechnology startup founded in 2013 with a mission to enable faster and deeper genomic diagnosis & research, and to bring genomic healthcare to all who need it. The company collaborates with the NHS to advance the use of genomic healthcare and research in the UK, aiming to help people live longer, healthier lives.
Genomics is a pioneering area of medicine that utilizes unique genetic codes to aid in diagnosing, treating, and preventing illnesses. Through advanced technology, scientists can compare numerous genetic codes to make new discoveries that continually enhance genomic healthcare.
In 2013, Genomics England and the NHS initiated the 100,000 Genomes Project, showcasing how genomic insights can assist doctors across the NHS and laying a foundation for the future by compiling a unique dataset. The company is currently supporting the NHS in delivering genomic testing for patients as part of routine healthcare, and providing health data and technology necessary for researchers to make new discoveries and develop more effective, targeted medicines.
Genomics England collaborates with thousands of individuals including patients, doctors, and scientists to expand collective knowledge and facilitate faster and deeper genomic research, ultimately striving to make genomic healthcare accessible to all in need.
There is no investment information
No recent news or press coverage available for Genomics England.